Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Indonesia
94%
Indonesian
65%
Insulin Resistance
41%
Type 2 Diabetes Mellitus Patients
37%
Obesity
36%
Type 2 Diabetic Patients
31%
Type 1 Diabetes Mellitus (T1DM)
27%
Waist Circumference
26%
Jakarta
25%
Meta-analysis
24%
Risk Factors
22%
Metabolic Syndrome
20%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
20%
Pada
19%
Systematic Meta-analysis
19%
Anthelmintic Treatment
17%
Helminths
16%
Body Mass Index
16%
Diabetes
16%
Cluster Randomized Trial
15%
Ramadan Fasting
15%
Helminth Infection
14%
Diabetes Melitus
14%
TipE
14%
Diabetes Management
13%
Adiposity
13%
Graves' Disease
12%
Hemoglobin A1c (HbA1c)
12%
Pre-diabetes (pre-DM)
12%
COVID-19 Patients
12%
National Health Survey
12%
Peripheral Arterial Disease
12%
Metabolic Profiling
12%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
12%
Bogor
12%
Hypoglycemia
12%
Middle-aged
12%
Soil-transmitted Helminths
11%
Randomized Placebo-controlled Trial
11%
Clinical Practice Guidelines
11%
COVID-19
11%
Hypertension
11%
COVID-19 Severity
10%
Fasting Plasma Glucose
10%
Adiponectin
10%
Poor Prognosis
9%
Lipid Accumulation Product
9%
Leptin
9%
Lipid Accumulation Product Index
9%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
89%
Diabetes
58%
Systematic Review
31%
Body Mass Index
30%
COVID-19
27%
Insulin Resistance
26%
Prevalence
23%
Diabetes Mellitus
23%
Meta-Analysis
21%
Metabolic Syndrome
15%
Randomized Controlled Trial
14%
Helminth
14%
Blood Glucose
14%
Type 2 Diabetes
13%
Adiponectin
13%
Impaired Glucose Tolerance
13%
Lipid Storage
13%
Cohort Analysis
12%
Patient Referral
12%
Non Communicable Disease
12%
Health Survey
12%
Quality of Life
12%
Leptin
11%
Homeostatic Model Assessment
11%
Glycemic Control
11%
Ramadan Fasting
11%
Hemoglobin A1c
10%
Cardiovascular Disease
10%
Patient with Type 2 Diabetes
10%
Helminthiasis
10%
Placebo
9%
Cardiovascular System
9%
Cross Sectional Study
9%
Triacylglycerol
9%
Diseases
9%
Health Care Cost
9%
Graves' Disease
9%
Anthropometry
8%
Primary Health Care
8%
Hypoglycemia
8%
Diabetic Foot Ulcer
7%
Oral Antidiabetic Agent
7%
Middle Age
7%
Diabetic Ketoacidosis
7%
C-Peptide
7%
High Fat Food
7%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Latent Autoimmune Diabetes in Adults
7%
Endocrine Ophthalmopathy
7%
Autoimmunity
7%